Int J Cancer 1998,78(2):135–139.PubMedCrossRef 12. Blaser MJ, Perezperez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A: Infection with Helicobacter-pylori Strains Possessing Caga Is Associated with an Increased Risk of Developing Adenocarcinoma of the Stomach. Cancer Res 1995,55(10):2111–2115.PubMed 13. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, Hatakeyama M: SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science

find more 2002,295(5555):683–686.PubMedCrossRef 14. Naito M, Yamazaki T, Tsutsumi R, Higashi H, Onoe K, Yamazaki S, Azuma T, Hatakeyama M: Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology 2006,130(4):1181–1190.PubMedCrossRef 15. Azuma T, Yamazaki S, Yamakawa A, Ohtani M, Muramatsu A, Suto H, Ito Y, Dojo M, Yamazaki Y, Kuriyama M, et al.: Association between diversity in the Src homology Selleck IWR-1 2 domain-containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J Infect Dis 2004,189(5):820–827.PubMedCrossRef 16. Choi KD, Kim

N, Lee DH, Kim JM, Kim JS, Jung HC, Song IS: Analysis of the 3 ‘ variable region of the cagA gene of Helicobacter pylori isolated in Koreans. Digest Dis Sci 2007,52(4):960–966.PubMedCrossRef 17. Zhu YL, Zheng S, Du Q, Qian KD, Fang PC: Characterization of CagA variable region of Helicobacter pylori isolates from Chinese patients. World J Gastroenterol 2005,11(6):880–884.PubMed 18. Yamaoka Y, El-Zimaity Protein tyrosine phosphatase HMT, Gutierrez O, Figura N, Kim JK, Kodama T, Kashima K, Graham DY: Relationship between the cagA 3 ‘ repeat region of Helicobacter pylori , gastric histology, and susceptibility to low pH. Gastroenterology 1999,117(2):342–349.PubMedCrossRef

19. Basso D, Zambon CF, Letley DP, Stranges A, Marchet A, Rhead JL, Schiavon S, Guariso G, Ceroti M, Nitti D, et al.: Clinical relevance of Helicobacter pylori cag A and vac A gene polymorphisms. Gastroenterology 2008,135(1):91–99.PubMedCrossRef 20. Argent RH, Kidd M, Owen RJ, Thomas RJ, Limb MC, Atherton JC: Determinants and Temsirolimus consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori . Gastroenterology 2004,127(2):514–523.PubMedCrossRef 21. Sicinschi LA, Correa P, Peek RM, Camargo MC, Piazuelo MB, Romero-Gallo J, Hobbs SS, Krishna U, Delgado A, Mera R, et al.: CagA C-terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions. Clin Microbiol Infect 2010,16(4):369–378.PubMedCrossRef 22. Acosta N, Quiroga A, Delgado P, Bravo MM, Jaramillo C: Helicobacter pylori CagA protein polymorphisms and their lack of association with pathogenesis. World J Gastroentero 2010,16(31):3936–3943.CrossRef 23.